1. Home
  2. AR vs MDGL Comparison

AR vs MDGL Comparison

Compare AR & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Resources Corporation

AR

Antero Resources Corporation

HOLD

Current Price

$34.39

Market Cap

10.8B

Sector

Energy

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$527.62

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AR
MDGL
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
11.1B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
AR
MDGL
Price
$34.39
$527.62
Analyst Decision
Buy
Strong Buy
Analyst Count
16
12
Target Price
$47.13
$674.45
AVG Volume (30 Days)
4.9M
289.8K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1027.78
41.32
EPS
1.72
N/A
Revenue
$5,275,823,000.00
$180,133,000.00
Revenue This Year
$29.74
$58.39
Revenue Next Year
$5.07
$48.55
P/E Ratio
$20.03
N/A
Revenue Growth
21.97
N/A
52 Week Low
$29.10
$284.02
52 Week High
$45.75
$615.00

Technical Indicators

Market Signals
Indicator
AR
MDGL
Relative Strength Index (RSI) 44.36 63.06
Support Level $32.85 $498.59
Resistance Level $35.68 $545.29
Average True Range (ATR) 1.04 18.48
MACD 0.12 4.67
Stochastic Oscillator 52.12 97.73

Price Performance

Historical Comparison
AR
MDGL

About AR Antero Resources Corporation

Antero Resources is an exploration and production firm whose operations represent a pure play in the Marcellus Shale, located in northern West Virginia. The company started in 2002 as an E&P focused on the Barnett Shale (Fort Worth, Texas). Antero redefined itself in Appalachia's Marcellus Shale in 2005. In 2012, shortly before Antero's 2013 IPO, Antero Midstream Partners was formed to handle the company's rapidly growing gas volumes. In 2026, the firm narrowed its focus further by selling its Ohio Utica assets and using the proceeds to acquire additional Marcellus acreage from HG Energy. Just over half of its production and earning power is tied to natural gas, with the remainder mostly NGLs, where it holds a leading position, and some crude oil.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: